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A B S T R A C T
For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have
isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and
uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the antifungal efficacy, extracts of B.
velezensis DTU001 was tested against a range of twenty human or plant pathogenic fungi. We demonstrate that
inhibitory potential of B. velezensis DTU001 against selected fungi is superior in comparison to single lipopeptide,
either iturin or fengycin. The isolate showed analogous biofilm formation to other closely related Bacilli. To
further support the biocontrol properties of the isolate, coculture with Candida albicans demonstrated that B.
velezensis DTU001 exhibited excellent antiproliferation effect against C. albicans. In summary, the described
isolate is a potential antifungal agent with a broad antifungal spectrum that might assist our aims to avoid
hazardous pathogenic fungi and provide alternative to toxicity caused by chemicals.
1. Introduction
The prerequisite for benign and effective antifungal agents increases
in parallel with the existing and escalating emergence of fungal pa-
thogens resistant to current therapies [1], being relevant to both ther-
apeutics and biocontrol. While infectious diseases impose serious public
health burden and often have devastating consequences, plant diseases
constitute an emerging threat to global food security. Additionally,
extensive use of chemicals to control plant diseases has distressed the
ecological balance of microbes inhabiting soil. This in turn has led to
the appearance of resistant pathogenic strains, groundwater con-
tamination, and obvious health risks to human beings. Thus, the iden-
tification and development of environmental friendly alternatives to the
currently used chemical pesticides for combating a variety of crop
diseases is nowadays one of the biggest ecological challenges [2]. It is
therefore vital to obtain a broad range of antifungal agents that are non-
hazardous to human health as well as to the environment.
Several microorganisms have so far been discovered for the devel-
opment of biopesticides at commercial level. Among the various mi-
croorganisms, Bacillus spp., Pseudomonas spp., and some mycorrhizal
fungi are widely used groups for biocontrol [3]. Especially, the Bacillus
genus is proven to be source an excellent source of antifungal agents
and thus Bacilli are widely used as biocontrol agents [4,5]. The US Food
and Drug Administration (US FDA) declared Bacillus subtilis as GRAS
(generally recognized as safe) organisms for its use in food processing
industries [6]. Members of the B. subtilis groups were found to produce
numerous highly active antifungal compounds [7]. The B. subtilis group
contains the “Operational Group Bacillus amyloliquefaciens” that in-
cludes B. amyloliquefaciens, Bacillus velezensis, and Bacillus siamensis [8].
Among these, B. velezensis FZB42 (formerly B. amyloliquefaciens subsp.
plantarum FZB42) is the most researched commercially used Bacillus-
based biofertilizer and biocontrol agent in agriculture [9].
Antifungal cyclopeptides appeared to play a major role in biological
control of plant pathogens [4,10]. Composed of a peptide and a fatty
acyl moiety, these amphiphilic metabolites have consolidated their
position as potent therapeutic compounds, such as daptomycin, a li-
popeptide antibiotic used in human medicine [11]. Antibacterial, -viral,
-fungal, -tumor activity and immune-modulatory effects are some of
their proven and emerging properties [12]. In addition, secondary
metabolites seem to play an important role in bacterial-fungal
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interaction of Bacilli [13] and other bacterial life styles, including sur-
face spreading [14–16].
Here, we describe a new Bacillus isolate DTU001, which exhibited a
broad and strong antifungal spectrum against different pathogenic
fungi ranging from plant pathogens to human pathogens. Using in silico
DNA hybridization, it was identified as B. velenzensis. To dissect the
genetic potential as an antifungal agent, we genome-mined BGCs in 31
Bacillus species and compared their biosynthetic potential with a special
focus on commercially applied strains. To detect the synthesized sec-
ondary metabolites of B. velezensis DTU001, the lipopetide profile of the
strain's crude extract was investigated.
Lipopeptides produced by Bacilli, such as iturin, fengycin and sur-
factin are believed to contribute to their antifungal potential. When
new isolates from the B. subtilis species complex are evaluated, the role
of single lipopeptide in antifungal activity is scrutinized lacking sys-
tematic in vitro evaluation of the antifungal efficacy of the combination
of these secondary metabolites. To fill in this gap, we also studied the
efficacy of extracted iturin and fengycin in comparison to the crude
extract of B. velezensis DTU001 using twenty critical human or plant
pathogens. In this report, we outline the phylogeny, genomics, meta-
bolomics, biofilm formation, and antifungal effects of B. velezensis
DTU001.
2. Materials and methods
2.1. Bacterial and fungal strains
B. velezensis DTU001 is an airborne bacterium, isolated indoor at the
DTU campus, Kongens Lyngby Denmark. Twenty selected plant/human
pathogens (Table 1) covering five genera Aspergillus, Penicillium, Ta-
laromyces, Cryptococcus and Candida were obtained from the DTU
Bioengineering IBT fungal collection. All microbes are maintained at
the department.
2.2. Genome sequencing
Genomic DNA was isolated from B. velezensis DTU001 using
Bacterial and Yeast Genomic DNA kit (EURx, Poland). Genome se-
quencing has been performed on PacBio RSII platform, de novo
assembly and annotation were done using the RS HGAO Assembly
(v3.0) and Prokka (v1.12b) software, respectively. The complete se-
quence has been deposited in NCBI (accession number CP035533)
followed by automatic annotation via NCBI PGAP [17].
2.3. Chemicals
Solvents used in this study were LC–MS grade, and all other che-
micals were analytical grade. Iturin A, fengycin and solvents as well
were from Sigma-Aldrich (Steinheim, Germany) unless otherwise
stated. Water was purified using a Milli-Q system (Millipore, Bedford,
MA). ESI–TOF tune mix was purchased from Agilent Technologies
(Torrance, CA, USA).
2.4. Digital DNA–DNA hybridization (dDDH)
The genome-to-genome-distance calculator (GGDC) version 2.1
provided by DSMZ (http://ggdc.dsmz.de/) was used for genome-based
species delineation [18] and genome-based subspecies delineation [19].
Distances were calculated by (i) comparing two genomes using the
chosen program to obtain HSPs/MUMs and (ii) inferring distances from
the set of HSPs/MUMs using three distinct formulas. Next, the distances
were transformed to values analogous to DDH. The DDH estimates were
based on an empirical reference dataset comprising real DDH values
and genome sequences. The DDH estimate resulted from a generalized
linear model (GLM) which also provided the estimate's confidence in-
terval. Three formulas are available for the calculation: (1) HSP length/
total length; (2) identities/HSP length; and (3) identities/total length.
Formula 2, which is especially appropriate to analyze draft genomes,
was used in this study.
2.5. Construction of the evolutionary tree
An initial whole genome phylogeny was inferred using the automlst
tool (http://automlst.ziemertlab.com; [38]). This automatically iden-
tifies related strains based on a seed collection of sequences obtained
from NCBI Genbank (B. velezensis DTU001, B. thuringiensis serovar
Berliner ATCC 10792, B. cereus 03BB102, B. megaterium DSM319, B.
velezensis FZB42), using a MASH-based algorithm, that extracts 80
Table 1
Bioactivity of iturin (1mg/mL), fengycin (1mg/mL), and crude B. velezensis extract (1mg/mL) against 16 human- and plant-pathogenic filamentous fungi and 4
yeasts. No inhibition is denoted with "-", while faint inhibition is labeled "+".
Name of the fungi Strain information Zone of inhibition (mm)
Iturin Fengycin B. velezensis
supernatant
A. niger IBT27878 Harvest decay of fresh and dried fruits and certain vegetables, nuts, beans, and cereals 27 – 25
A. terreus IBT22089 Opportunistic human pathogen; crops pathogen, e.g. wheat, ryegrass, and potatoes 20 – 19
A. felis IBT34215 Causative agent of Aspergillosis in humans, dogs and cats – – –
A. flavus IBT32105 30 – 26
T. amestolkiae IBT23485 Common cosmopolitan species that has been cultured from indoor house dust, sputum and lungs from
cystic fibrosis patients, indoor air, wheat, soil, pineapple, sculptures and manure
26 20 24
T. atroroseus IBT11181 29 20 30
P. expansum IBT34672 24 – 20
P. frequentans IBT34879 25 – 23
P. italicum IBT34168 30 – 33
P. digitatum IBT34217 + – +
P. ulaiense IBT23038 30 – 30
P. arizonense IBT12857 + – +
P. solitum IBT34928 33 – 33
P. sclerotigenum IBT30034 Opportunistic human infection, associated with blue mold of yam in Korea – – 32
A. uvarum IBT32575 Contamination of several agricultural products, including grape-derived products, coffee and cocoa 25 – 35
A. calidoustus IBT28322 Opportunistic human infection – – 32
C. albicans IBT654 Superficial and serious systemic diseases 21 – 19
C. albicans IBT657 24 – 20
C. neoformans IBT10488 30 – 31
C. neoformans IBT10496 26 – 29
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phylogenetically relevant genes and builds a MLST phylogeny out of
these data. The sequence alignment obtained from automlst was then
manually refined (removal of very similar species). To infer the best
phylogenetic model, jModeltest (v.2.1.10) was used with default para-
meters [20]. In all three evaluation criteria (Akaike Information Cri-
terion AIC, Bayesian Information Criterion BIC and the Decision
Therory Performance-based Selection), the GTR + I + G model was
deemed most suitable. Thus, a maximum-likelihood tree was con-
structed in PhyML (v3.3.20180621) [21] using the parameters sug-
gested by jModeltest. The tree then was checked with Dendroscope
(v3.5.10) [22] and plotted using the ETE3 toolkit [23].
2.6. Genome mining of secondary metabolites
B. velezensis DTU001 and other 32 Bacillus strains were mined for
the biosynthetic gene clusters using the antiSMASH platform [24] and
BiG-SCAPE [25].
2.7. Agar-diffusion assay
Agar-diffusion assay was carried to test the anti-fungal activities. B.
velezensis DTU001 grown on agar plates was extracted by ethyl acetate,
concentrated and re-dissolved in methanol (1mg/mL). DMSO was used
as a negative control. Initial screening of the bacterial extract was done
by standard agar disc diffusion method [26] and the zone of inhibition
was noted. The 16 pathogenic filamentous fungi were grown on sterile
MEAOX plates and the 4 yeasts were cultivated on PDA at 25 °C. 5-days
old fungal plates and 2-days old yeast plates were taken for further
investigation. Spore suspensions harvested in tween 20 from MEAOX
medium plates with a final cell concentration of 5×105 cfu/mL of each
microbial culture (fungi and yeast) were maintained for the disc dif-
fusion assay. Plugs were harvested from 48 h grown B. velezensis
DTU001 from MEAOX plates and extracted in isopropanol-ethyl
acetate-1% formic acid followed by 1 h ultra-sonication. The super-
natant was collected and dried utilizing nitrogen evaporator. The test
sample (B. velezensis extract) and the standard compounds (iturin and
fengycin) were dissolved in 0.5% DMSO to a concentration of 1mg/mL
each. Sterile Muller Hinton Agar plates were inoculated with the test
organisms using lawn culture method. Discs of 6mm were cut at the
centre of the sterile plates using a sterile cork borer. The discs were
loaded with 50 μl of each test sample. The plates were maintained at
25 ± 2 °C for 5 days and observed for clear zone of inhibition. Iturin
and fengycin standards were maintained as positive control. Blank as-
says in DMSO were applied to avoid any possible effect of the solvent.
Each experiment was conducted in triplicates for further confirmation
and reproducibility of results.
2.8. Anti-Candida effects under planktonic and biofilm conditions
The impact of B. velezensis DTU001 on C. albicans SC5314 reference
strain was assayed. C. albicans and B. velezensis were subcultured on
Sabouraud dextrose agar and lysogeny broth (LB) agar, respectively.
The growth of the individual strains in both monoculture and coculture
was evaluated in order to examine the effect of B. velezensis on C. al-
bicans planktonic growth. The final cell concentrations were adjusted to
2× 105 cells/ml in RPMI-1640 broth + LB broth (50:50 v/v %) both
for C. albicans and B. velezensis. Test tubes were incubated with agita-
tion in darkness at 35 °C. 100 μl culture was removed at 0, 2, 4, 6, 8, 12
and 24 h, serially diluted tenfold in sterile physiological saline then
plated onto either Sabouraud dextrose agar or LB agar. Plates were
incubated for 24 and 48 h at 35 °C for B. velezensis and C. albicans, re-
spectively. Results are representative of three independent experiments
and are expressed as mean ± SD (error bars), which was presented
using GraphPad Prism 6.05.
For the biofilm assays, polystyrene flat-bottom 96-well microtiter
plates (TPP, Trasadingen, Switzerland) were used for the formation of
single and mixed species biofilms of C. albicans and B. velezensis. A
volume of 200 μl of cell suspension (1× 106 cells/mL in RPMI-1640
broth + LB broth (50:50 v/v%) for C. albicans and 1× 106 cells/mL in
RPMI-1640 broth + LB broth (50:50 v/v%) for B. velezensis) was pi-
petted to each well for single biofilms, while 100 μL from each sus-
pension (2× 106 cells/mL for C. albicans with 2× 106 cells/ml for B.
velezensis) was added for mixed species biofilms to wells assigned to
endpoints 2, 4, 6, 8, 12 and 24 h. The plates were incubated in darkness
with static conditions. After 2, 4, 6, 8, 12 and 24 h of incubation, the
corresponding wells were washed three times with sterile physiological
saline then 200 μL sterile saline was added into wells, scraped off the
adhered cells from surfaces; afterwards, aliquots of 100 μL were re-
moved. Cells were released by mild sonication and vortexing then di-
luted serially ten-fold and plated onto either Sabouraud dextrose agar
or LB agar. Plates were incubated for 24 and 48 h at 35 °C for B. vele-
zensis and C. albicans, respectively. Results are representative of three
independent experiments and are expressed as mean ± SD (error
bars), which was presented using GraphPad Prism 6.05.
2.9. Bacterial biofilm formation
Bacterial strains (B. velezensis DTU001, B. subtilis NCBI 3610 [28], B.
subtilis ATCC6633 (ATCC collection), B. subtilis PS216 [27], B. velezensis
FZB42 (obtained from Bacillus Genetic Stock Centre), and B. methylo-
trophicus NCCB100236 (obtained from Bacillus Genetic Stock Centre))
were inoculated in lysogeny broth (Lenox LB, Carl Roth, Germany) and
grown overnight for 16 h at 37 °C at 225 rpm. For pellicle development
20 μl was inoculated in 2mL MSgg medium and placed in a 24-well
plate, while 5 μL spotted on MSgg medium solified with 1,5% agar that
was prepared as described previously [8,28]. Both pellicle and colony
biofilms were incubated at incubated at 30 °C static conditions and
imaged after 3 days.
2.10. Secondary metabolites identification
A UHPLC–DAD–QTOF method was set up for screening, with typical
injection volumes of 0.1–2 μL extract. Separation was performed on a
Dionex Ultimate 3000 UHPLC system (Thermo Scientific, Dionex,
Sunnyvale, California, USA) equipped with a 100×2.1mm, 2.6 μm,
Kinetex C18 column, held at a temperature of 40 °C, and using a linear
gradient system composed of A: 20mmol L−1 formic acid in water, and
B: 20mmol L−1 formic acid in acetonitrile. The flow was 0.4 mLmin−1,
90% A graduating to 100% B in 10min, 100% B 10–13min, and 90% A
13.1–15min.
Time-of-flight detection was performed using a maXis 3G QTOF
orthogonal mass spectrometer (Bruker Daltonics, Bremen, Germany)
operated at a resolving power of ∼50000 full width at half maximum
(FWHM). The instrument was equipped with an orthogonal electro-
spray ionization source, and mass spectra were recorded in the range
m/z 100–1500 as centroid spectra, with five scans per second. For ca-
libration, 1 μL 10mmol L−1 sodium formate was injected at the be-
ginning of each chromatographic run, using the divert valve
(0.3–0.4min). Data files were calibrated post-run on the average
spectrum from this time segment, using the Bruker HPC (high-precision
calibration) algorithm.
For ESI+ the capillary voltage was maintained at 4200 V, the gas
flow to the nebulizer was set to 2.4 bar, the drying temperature was
220 °C, and the drying gas flow was 12.0 Lmin−1. Transfer optics (ion-
funnel energies, quadrupole energy) were tuned on HT-2 toxin to
minimize fragmentation. For ESI− the settings were the same, except
that the capillary voltage was maintained at −2500 V. Unless otherwise
stated, ion-cooler settings were: transfer time 50 μs, radio frequency
(RF) 55 V peak-to-peak (Vpp), and pre-pulse storage time 5 μs.
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3. Results and discussion
3.1. The genome of the indoor airborne isolate B. velezensis DTU001
encodes numerous secondary metabolites
B. velezensis DTU001 was isolated indoor at the DTU campus in
Denmark and selected for detailed analysis based on its potential an-
timicrobial activity. The complete genome sequence of B. velezensis
DTU001 consisted of a circular 3.927.210 bp chromosome with a GC
content of 46.6%. Its 16S rRNA gene sequence exhibited 99% similarity
to B. velezensis and B. amyloliquefaciens in genome database.
The phylogenetic affiliation of DTU001 isolate was further in-
vestigated using digital DNA:DNA-hybridization (dDDH) similarities
and differences in genomic G + C content. (https://ggdc.dsmz.de/).
These distances are transformed to values analogous to DDH using a
generalized linear model (GLM) inferred from an empirical reference
dataset comprising real DDH values and genome sequences. Compared
to B. velezensis FZB42 (NC-009725.1), DDH value of 80.3%, difference
in % G + C: 0.10. Meanwhile, there is a DDH analogous value of B.
amyloliquefaciens (FN597644.1) 55.4%, difference in % G + C: 0.51.
This result clearly supports that DTU001 is closer related to B. vele-
zensis, where the DDH value exceeded the threshold of 70%.
A phylogenetic analysis with automlst (http://automlst.ziemertlab.
com) was carried out, which automatically extracts 80 conserved genes,
concatenates them, computes a multiple sequence alignment and builds
a phylogenetic tree. The sequence alignment was manually checked,
and a maximum-likelihood tree refined with jModelTest2 [30] and
PhyML [21]. According to the MLST analysis, B. velezensis DTU1 forms a
clade with other Bacilli that were recently proposed to be assigned the
new species Bacillus lentimorphus [29].
To determine the genetic potential of B. velezensis DTU001 as bio-
control strain, the complete genome was surveyed for biosynthetic gene
clusters that identified nine gene clusters involved in nonribosomal
synthesis of lipopeptides, polyketides, and siderophore bacillibactin.
About 15.4% of the whole DTU001 genome was devoted to secondary
metabolites synthesis of nonribosomal synthesis of antimicrobial com-
pounds and siderophores. In addition, genes for synthesis of the highly
bioactive extracellular alkaline guanyl-preferring ribonuclease, pre-
viously detected in B. amyloliquefaciens [30] was also identified in the
genome of DTU001.
In order to compare the biosynthetic potentials between different
Bacilli, B. velezensis together with other 17 species were mined for the
genetic potential of secondary metabolite production using antiSMASH
and BiG-SCAPE. All Bacilli related to B. velezensis DTU001 have the
genetic potential to utilize bacillibactin as a siderophore to acquire
irons from the environments (Fig. 1). All selected B. amyloliquefaciens,
B. velezensis, and B. subtilis strains showed high similarities in BGC
potentials and are considered as talented strains producing various li-
popetides or polyketides. More distantly related Bacillus strains, such as
members of the Bacillus cereus group showed a different secondary
metabolite production genotype. All of these strains (B. cereus, B. an-
thracis, B. thuringiensis) seem to be unable of producing lipopeptides of
the surfactin, iturin or fengycin families.
3.2. Antifungal characterization of B. velezensis
Iturins are well-known secondary metabolites important for bio-
control against plant pathogens such as Xanthomonas campestris subsp.
Cucurbitae, Pectobacterium carotovorum subsp. Carotovorum, Rhizoctonia
solani, Fusarium graminearum etc. [31,32]. However, the impact of
iturins against medically-relevant fungal pathogens is less explored.
Therefore, we tested the efficacy and target specificity of DTU001
against selected important plant and human pathogenic fungi. In ad-
dition, we compared the effectiveness of the DTU001 crude extract and
the purified lipopeptides, iturin and fengycin. We have selected 17
important plant and human pathogenic filamentous fungi (Table 1)
ranging from the genera Penicillium, Aspergillus, Talaromyces, Candida to
Cryptococcus. Besides those notorious plant pathogens such as Asper-
gillus uvarum infecting grapes, citrus rotting Penicillium ulaiense and
post-harvest pathogen Penicillium expansum infecting apples, several
important human pathogens were tested, such as Aspergillus niger and
Candida.
The organic extracts of B. velezensis DTU001 displayed strong anti-
fungal effects against A. uvarum, P. ulaiense and P. expansum (Table 1
and Fig. 2). Due to the susceptibility to infection of mature and overripe
fruit, post-harvest treatment of fruit with fungicides has traditionally
been the most common method of combating P. expansum. Also, bio-
fungicides using active ingredients such as bacteria and yeast have been
successful in preventing infection but are ineffective against existing
infections [33]. Considering the size of the apple product industry and
the large number of people that may come into contact with infected
fruits, control of the P. expansum is vitally important. Interestingly both
Talaromyces atroroseus and Talaromyces amestolkiae were inhibited by
both fengycin (20mm) and iturin (29, 26mm) as well as the crude
extract (Table 1 and Fig. 2). All the tested organisms showed less or no
susceptibility towards fengycin.
In summary, the agar diffusion test showed that iturin and fengycin
displayed selective anti-fungal activities against certain fungal patho-
gens, which means that some strains are insensitive to the addition of a
single purified compound. For example, neither iturin nor fengycin
displayed activities against Penicillium sclerotigenum and Aspergillus ca-
lidoustus. Overall, iturin displayed stronger and broader activities
compared to fengycin. Compared to iturin and fengycin standards, ex-
tracts of B. velezensis DTU001 exhibited stronger inhibition activities
and displayed a broader spectrum against test fungi including P. scler-
otigenum and A. calidoustus. One explanation might be that B. velezensis
produced a cocktail mixture which functions in a synergistic and more
effective manner or additional secondary metabolite plays a role in the
inhibition. However, the combined impact of the lipopeptides could
avoid fast resistance evolution and help the bacterium in the environ-
mental survival. It seemed that Aspergillus felis harbored certain me-
chanisms to avoid anti-fungal effects from B. velezensis DTU001 as
neither lipopeptide standards nor the bacterial crude extract displayed
inhibition activities against this fungus.
3.3. B. velezensis DTU001 is able to weaken biofilms of C. albicans
As B. velezensis DTU001 showed broad anti-fungal activity spec-
trum, we further evaluated if the bacterial isolate can directly reduce
the growth of the human pathogen fungus, C. albicans under planktonic
conditions and during biofilm development. First, the growth of the
fungus and bacterium was monitored in planktonic co-cultures and
compared to the mono-cultures (Fig. 3). Importantly, the B. velezensis
cell count in the coculture with C. albicans did not differ significantly
compared to the monoculture. In contrast, C. albicans planktonic cells
between 6 and 24 h diminished in the presence of B. velezensis DTU001,
therefore the bacterial isolate was able to inhibit the proliferation of the
fungus in the co-cultures. Similarly, B. velezensis DTU001 was able to
reduce the biofilms of C. albicans when co-cultured. The inhibitory ef-
fect was even higher that under planktonic conditions after 24 h (2-log
decrease in fungal cell count). These experiments further support the
applicability of B. velezensis DTU001 as biocontrol agent even in the
presence of the target organism.
3.4. B. velezensis DTU001 is a potent biofilm former
The probiotic effects of Bacilli depend on the ability to form biofilm
and production of a matrix, that acts as an immune system stimulator
[34], protects from environmental stress [35], and is required for plant
colonization [36,37]. Therefore, we have compared the biofilm for-
mation of B. velezensis DTU001 to other Bacillus species known for
biofilm formation. Both architecturally complex colonies on agar
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Fig. 1. Evolutionary relationships of taxa between B. velezensis DTU001 and other Bacilli. A maximum-likelihood phylogenetic tree based on 80 conserved genes of
selected strains of Bacilli is shown; B. megaterium DSM 319 was selected as outgroup. The presence/absence of typical Bacillus BGCs is depicted on the right.
Fig. 2. Extracts of B. velezensis DTU001 against fungi showing clear inhibition zones. Images left to right: P. frequentans, A. niger and T. amestolkiae. DMSO control
loaded to the left hole, while the crude extract was applied to the right hole demonstrating the specific inhibition zone against the fungi.
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medium and air-liquid localized pellicles were tested. The biofilm de-
velopment can be qualitatively monitored using these models: the more
complex structures and enhanced wrinkles produced, the increased the
biofilm development of Bacilli [28,37]. In addition, pellicle formation
strongly depends on the matrix components, without which cell are
unable to float on the air-medium interface [8]. Both the architecturally
complex biofilm colonies and the pellicles showed robust biofilm for-
mation (i.e. wrinkled pellicles and colonies) by B. velezensis DTU001
that was comparable to other closely related isolates from the B. subtilis
species complex (Fig. 4).
3.5. Secondary metabolites characterization of B. velezensis DTU001
Based on the genome sequences and antifungal activity, B. velezensis
DTU001 was predicted to produce various lipopeptides. To specifically
demonstrate these secondary metabolites, LC-HRMS analysis was per-
formed on ethyl acetate extracts harvested from agar grown B. velezensis
DTU001. Indeed, chemical analysis along with purified standards de-
tected three groups of bioactive lipopeptides: iturins, fengycins, and
surfactins (Fig. 5, Figs. S1, S2, S3 and S4 in the supplemental data).
4. Conclusions
Through genomics and metabolomics investigation, we demon-
strated that B. velezensis DTU001 harbored the capacity to produce
bioactive lipopeptides, comparable to the commercially utilized B.
amyloliquefaciens and B. velezensis strains. Production of bioactive
iturin, fengycin and surfactin by this strain was confirmed by HPLC-
HRMS. Phylogenetic distance between DTU001 and those commercially
utilized B. amyloliquefaciens together with their shared chemistry makes
DTU001 as an attractive biocontrol option. Additionally, our targeted
comparative genomics study revealed the versatility of secondary me-
tabolite production by the selected Bacilli.
Either iturin or fengycin were previously proposed to be responsible
for the antifungal activities of isolates within the B. subtilis species
complex, however, we propose here that a cocktail anti-fungal agent
derived from the crude extract of B. velezensis DTU001 functions more
efficiently than single components. In addition, it will be interesting to
examine whether purified surfactin also impacts the inhibitory poten-
tial of DTU001. In summary, this newly described isolate can be utilized
as a biocontrol agent with a broad antifungal spectrum and provides a
sustainable alternative for replacement of hazardous chemicals.
Fig. 3. Planktonic (A) and biofilm (B) cul-
tivation of C. albicans SC5314 and B. vele-
zensis DTU001. Colony forming units were
recorded at the indicated time points for C.
albicans (open rhombus indicates C. albicans
alone, open square denotes C. albicans in the
presence of B. velezensis) and B. velezensis
(open circle indicates B. velezensis alone,
filled circle denotes B. velezensis in the pre-
sence of C. albicans).
Fig. 4. Pellicle (above) and colony biofilms (below) of selected strains from the B. subtilis species complex. The ability of biofilm formation is indicated by the
development of wrinkles on the top of the pellicles and colonies. Scale bar indicates 5 mm.
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